Crescent Capital BDC, Inc. Hits New 52-Week Low at $10.51

Crescent Capital BDC, Inc. has reached a new 52-week low, trading at USD 10.51 as of August 26, 2026. This marks a significant decline for the microcap company, which operates within the capital markets industry. Over the past year, Crescent Capital has experienced a notable drop in performance, with a decline of 44.4%, contrasting sharply with the S&P 500's gain of 18.71%. The company's financial metrics reflect ongoing difficulties, including a substantial decrease in net sales by 27.34%. Crescent Capital has reported negative results for seven consecutive quarters, with pre-tax profit plummeting to USD -2.54 million, a decline of 160.41%. Additionally, net profit has fallen to USD -3.25 million, down 186.06%. The return on equity stands at 4.89%, while the price-to-book ratio is at 0.64, indicating potential valuation concerns. With a market capitalization of USD 455 million and a dividend yield of 14.92%, Crescent Capital BDC, Inc. continues to navigate a challenging financial landscape, marked by consistent underperformance against industry benchmarks.